JAN had earnings but I cannot find the report. It is trading with heavy volume and it shows in
the price action. Price has pulled back in the after-market in a standard Fibonacci retracement.
A pullback is appropriate here as price has gained 250% in a month. I see the pullback
as healthy and JAN is now well positioned for another bullish continuation....
Broke out of falling wedge around 109 and is moving well in the supply zone.
With two wars, geopolitical risks are high and this could play out as a good hedge.
First target would be around 117. New pivot there might set this up for higher price.
I am long from 109.50
ABT is Abbott Labs, a well-established medical technology company has had good earnings
twice this year. In the first episode, the price trended down then recovered in a retracement.
I have anchored a long-term mean VWAP and its standard deviations as a means to assess
areas of dynamic support and resistance. One week ago, the price crossed the mean VWAP...
Pure Value & Low Vol relative to Pure Growth & High Beta. The rotation away from duration and beta has been very strong the past 2 months. As QT begins and liquidity dries up even more, I’d continue to favor shorter duration & lower beta segments of the market.
Unilever has formed a small base on the daily chart inline with major support. There is also bullish divergence on the RSI and we believe scope for a bounce towards 3400p in the short term.
We could see this grind towards the target over the Christmas period.
